Use of minimally invasive approaches for stage I non-small cell lung cancer: A surgeon's point of view

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
P-A Thomas

Abstract

Lobectomy with lymphadenectomy is the standard of care of patients with early stage non-small cell lung cancer, and the use of minimally invasive approaches is associated with reduced morbidity when compared with thoracotomy. Segmentectomy with lymphadenectomy seems to provide a curative effect equivalent to that of lobectomy for stage IA tumours of 2 cm or smaller, and for pure or predominant ground glass opacities. The combination of lung-sparing resections with minimally invasive approaches results in preserved pulmonary function, improved quality of life and very low morbidity. This benefit persists in so-called high-risk patients. Among patients with clinical stage IA managed with sublobar resections, more than 25% are proved to have a more advanced pathologic stage at surgery, suggesting that alternative ablative therapies would result in an incomplete resection in a similar proportion. Moreover, resection samples tumour tissue that is adequate in quantity and quality, and provides material for "research biopsies" to consolidate tissue availability for clinical trials, translational research, and in biobanks.

References

Dec 1, 1992·The Annals of Thoracic Surgery·K KodamaH Yokouchi
Mar 14, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yi long WuWei Ou
May 9, 2002·The Annals of Thoracic Surgery·Koichi YoshikawaTakashi Mori
Feb 5, 2004·The Annals of Thoracic Surgery·Noriyoshi SawabataUNKNOWN Thoracic Surgery Study Group of Osaka University
Jun 30, 2004·The Annals of Thoracic Surgery·Robert J KeenanTibetha Santucci
Nov 25, 2005·The Annals of Thoracic Surgery·Hiroaki HaradaNoriaki Tsubota
May 6, 2006·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Keiji KushibeShigeki Taniguchi
Jan 19, 2007·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Wulf SienelBernward Passlick
May 17, 2007·Annals of Surgical Oncology·Amgad El-SherifRodney J Landreneau
Feb 12, 2008·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Wulf SienelBernward Passlick
Jan 22, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisDavid Yankelewitz
Jun 7, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sandro MattioliFrank D'ovidio
Jul 1, 2011·The New England Journal of Medicine·UNKNOWN National Lung Screening Trial Research TeamJoRean D Sicks
Jul 19, 2011·The Journal of Thoracic and Cardiovascular Surgery·Hisato TakagiTakuya Umemoto
Aug 11, 2011·The European Respiratory Journal·P E Van SchilW D Travis
Nov 23, 2011·The Journal of Thoracic and Cardiovascular Surgery·Bernard J ParkGiulia Veronesi
Sep 4, 2013·The Annals of Thoracic Surgery·Michael KentHiran C Fernando
Nov 21, 2013·The Journal of Thoracic and Cardiovascular Surgery·Matthew D TaylorDavid R Jones
Dec 11, 2013·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Feichao BaoJian Hu
Feb 18, 2014·The Journal of Thoracic and Cardiovascular Surgery·Daniel J BoffaSubroto Paul
Feb 19, 2014·The Annals of Thoracic Surgery·Varun PuriBryan F Meyers
Feb 21, 2014·Innovations : Technology and Techniques in Cardiothoracic and Vascular Surgery·Alexander S FarivarBrian E Louie
Feb 25, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J VansteenkisteUNKNOWN Panel Members
Mar 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marie WislezJean-Charles Soria
Dec 3, 2014·The Annals of Thoracic Surgery·Se Joong KimChoon-Taek Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.